Heating up cold agglutinins
Marvin J Stone, Marvin J Stone
Abstract
In this issue of Blood, Berentsen and coworkers describe a high response rate which is durable in some patients who receive combination fludarabine and rituximab for chronic cold agglutinin disease (CAD). If confirmed, this is a significant advance in therapy for a frequently difficult clinical problem.
Source: PubMed